相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Base Editor Correction of COL7A1 in Recessive Dystrophic Epidermolysis Bullosa Patient-Derived Fibroblasts and iPSCs
Mark J. Osborn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
Peter Gee et al.
NATURE COMMUNICATIONS (2020)
Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions
Francesca Ferrua et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
Rana Mhaidly et al.
CANCERS (2020)
Highly efficient 'hit-and-run' genome editing with unconcentrated lentivectors carrying Vpr.Prot.Cas9 protein produced from RRE-containing transcripts
Ivana Indikova et al.
NUCLEIC ACIDS RESEARCH (2020)
Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins (vol 11, 3778, 2020)
Giulia Pavani et al.
NATURE COMMUNICATIONS (2020)
Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration
Baohong Luo et al.
CELL DEATH & DISEASE (2020)
Essential Role of NADPH Oxidase-Dependent Production of Reactive Oxygen Species in Maintenance of Sustained B Cell Receptor Signaling and B Cell Proliferation
Yang-Yang Feng et al.
JOURNAL OF IMMUNOLOGY (2019)
Highly efficient therapeutic gene editing of human hematopoietic stem cells
Yuxuan Wu et al.
NATURE MEDICINE (2019)
CRISPR/Cas9-modified hematopoietic stem cells-present and future perspectives for stem cell transplantation
Alberto Daniel-Moreno et al.
BONE MARROW TRANSPLANTATION (2019)
Correction of IVS I-110(G>A) β-thalassemia by CRISPR/Cas- and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells
Petros Patsali et al.
HAEMATOLOGICA (2019)
HIV-specific humoral immune responses by CRISPR/Cas9-edited B cells
Harald Hartweger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Gene correction for SCID-X1 in long-term hematopoietic stem cells
Mara Pavel-Dinu et al.
NATURE COMMUNICATIONS (2019)
B cells engineered to express pathogen-specific antibodies protect against infection
Howell F. Moffett et al.
SCIENCE IMMUNOLOGY (2019)
NHEJ-Mediated Repair of CRISPR-Cas9-Induced DNA Breaks Efficiently Corrects Mutations in HSPCs from Patients with Fanconi Anemia
Francisco Jose Roman-Rodriguez et al.
CELL STEM CELL (2019)
Successful engraftment of gene-corrected hematopoietic stem cells in non-conditioned patients with Fanconi anemia
Paula Rio et al.
NATURE MEDICINE (2019)
In Vivo Selection for Gene-Corrected HSPCs Advances Gene Therapy for a Rare Stem Cell Disease
Bernhard Gentner et al.
CELL STEM CELL (2019)
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells
Elvin Wagenblast et al.
NATURE COMMUNICATIONS (2019)
Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I
Natalia Gomez-Ospina et al.
NATURE COMMUNICATIONS (2019)
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
Annalisa Lattanzi et al.
MOLECULAR THERAPY (2019)
CRISPR-Cas9 genome engineering of primary CD4(+) T cells for the interrogation of HIV-host factor interactions
Judd F. Hultquist et al.
NATURE PROTOCOLS (2019)
Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
Philippe E. Mangeot et al.
NATURE COMMUNICATIONS (2019)
Reprogramming the antigen specificity of B cells using genome-editing technologies
James E. Voss et al.
ELIFE (2019)
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors (vol 10, 5222, 2019)
Beau R. Webber et al.
NATURE COMMUNICATIONS (2019)
Efficient and Robust NK-Cell Transduction With Baboon Envelope Pseudotyped Lentivector
Aurelien B. L. Colamartino et al.
FRONTIERS IN IMMUNOLOGY (2019)
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency
Ornellie Bernadin et al.
BLOOD ADVANCES (2019)
Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
Chiara Antoniani et al.
BLOOD (2018)
The expansion of targetable biomarkers for CAR T cell therapy
Michelle H. Townsend et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins
Chung-An M. Wu et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2018)
Functional Interrogation of Primary Human T Cells via CRISPR Genetic Editing
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2018)
Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells
King L. Hung et al.
MOLECULAR THERAPY (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
A Survey of Validation Strategies for CRISPR-Cas9 Editing
Monica F. Sentmanat et al.
SCIENTIFIC REPORTS (2018)
Site-Specific Gene Editing of Human Hematopoietic Stem Cells for X-Linked Hyper-IgM Syndrome
Caroline Y. Kuo et al.
CELL REPORTS (2018)
Priming Human Repopulating Hematopoietic Stem and Progenitor Cells for Cas9/sgRNA Gene Targeting
Carsten T. Charlesworth et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
In vivo generation of human CD19-CAR T cells results in B-cell depletion and signs of cytokine release syndrome
Anett Pfeiffer et al.
EMBO MOLECULAR MEDICINE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Engineering of Primary Human B cells with CRISPR/Cas9 Targeted Nuclease
Matthew J. Johnson et al.
SCIENTIFIC REPORTS (2018)
Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout
Yvonne Knopp et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Guide Swap enables genome-scale pooled CRISPR-Cas9 screening in human primary cells
Pamela Y. Ting et al.
NATURE METHODS (2018)
Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
Jiangtao Ren et al.
CLINICAL CANCER RESEARCH (2017)
Gene Therapy for β-Hemoglobinopathies
Marina Cavazzana et al.
MOLECULAR THERAPY (2017)
Mapping the genomic landscape of CRISPR-Cas9 cleavage
Peter Cameron et al.
NATURE METHODS (2017)
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Preclinical modeling highlights the therapeutic potential of hematopoietic stem cell gene editing for correction of SCID-X1
Giulia Schiroli et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia
Zuzana Tothova et al.
CELL STEM CELL (2017)
Hematopoietic Stem Cell Gene Therapy: Progress and Lessons Learned
Richard A. Morgan et al.
CELL STEM CELL (2017)
Therapeutic gene editing in CD34+ hematopoietic progenitors from Fanconi anemia patients
Begona Diez et al.
EMBO MOLECULAR MEDICINE (2017)
Measles virus envelope pseudotyped lentiviral vectors transduce quiescent human HSCs at an efficiency without precedent
Camille Levy et al.
BLOOD ADVANCES (2017)
Engraftment and in vivo proliferation advantage of gene-corrected mobilized CD34+ cells from Fanconi anemia patients
Paula Rio et al.
BLOOD (2017)
Gene Editing of Human Hematopoietic Stem and Progenitor Cells: Promise and Potential Hurdles
Kyung-Rok Yu et al.
HUMAN GENE THERAPY (2016)
Baboon envelope pseudotyped lentiviral vectors efficiently transduce human B cells and allow active factor IX B cell secretion in vivo in NOD/SCIDγc-/- mice
C. Levy et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Hyper-active non-homologous end joining selects for synthetic lethality resistant and pathological Fanconi anemia hematopoietic stem and progenitor cells
Wei Du et al.
SCIENTIFIC REPORTS (2016)
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Michael C. Gundry et al.
CELL REPORTS (2016)
Receptor-Targeted Nipah Virus Glycoproteins Improve Cell-Type Selective Gene Delivery and Reveal a Preference for Membrane-Proximal Cell Attachment
Ruben R. Bender et al.
PLOS PATHOGENS (2016)
Practical utilization of recombinant AAV vector reference standards: focus on vector genomes titration by free ITR qPCR
Susan D'Costa et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)
Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency
Els Verhoeyen et al.
CURRENT GENE THERAPY (2016)
Retroviral integration: Site matters: Mechanisms and consequences of retroviral integration site selection
Jonas Demeulemeester et al.
BIOESSAYS (2015)
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Bernd Zetsche et al.
CELL (2015)
Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral Vectors
Qi Zhou et al.
JOURNAL OF IMMUNOLOGY (2015)
CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells
Christian Brendel et al.
MOLECULAR THERAPY (2015)
A Lentiviral Vector Allowing Physiologically Regulated Membrane-anchored and Secreted Antibody Expression Depending on B-cell Maturation Status
Floriane Fusil et al.
MOLECULAR THERAPY (2015)
BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
Matthew C. Canver et al.
NATURE (2015)
Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors
Jianbin Wang et al.
NATURE BIOTECHNOLOGY (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Adoptive cellular therapy: A race to the finish line
Carl H. June et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Quantifying on- and off-target genome editing
Ayal Hendel et al.
TRENDS IN BIOTECHNOLOGY (2015)
Genome-editing tools for stem cell biology
E. A. Vasileva et al.
CELL DEATH & DISEASE (2015)
Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs
Anais Girard-Gagnepain et al.
BLOOD (2014)
Mystery solved: VSV-G-LVs do not allow efficient gene transfer into unstimulated T cells, B cells, and HSCs because they lack the LDL receptor
Fouzia Amirache et al.
BLOOD (2014)
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Luke A. Gilbert et al.
CELL (2014)
Efficient Ablation of Genes in Human Hematopoietic Stem and Effector Cells using CRISPR/Cas9
Pankaj K. Mandal et al.
CELL STEM CELL (2014)
Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
Rajat M. Gupta et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Targeted genome editing in human repopulating haematopoietic stem cells
Pietro Genovese et al.
NATURE (2014)
CRISPR-Cas systems for editing, regulating and targeting genomes
Jeffry D. Sander et al.
NATURE BIOTECHNOLOGY (2014)
Generation of mouse models of myeloid malignancy with combinatorial genetic lesions using CRISPR-Cas9 genome editing
Dirk Heck et al.
NATURE BIOTECHNOLOGY (2014)
Targeted genome editing hits the clinic
Angelo Lombardo et al.
NATURE MEDICINE (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
The new frontier of genome engineering with CRISPR-Cas9
Jennifer A. Doudna et al.
SCIENCE (2014)
CD19 and CD20 Targeted Vectors Induce Minimal Activation of Resting B Lymphocytes
Sabrina Kneissl et al.
PLOS ONE (2013)
ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering
Thomas Gaj et al.
TRENDS IN BIOTECHNOLOGY (2013)
B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells
James N. Kochenderfer et al.
BLOOD (2012)
T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing
Qi Zhou et al.
BLOOD (2012)
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
Martin Jinek et al.
SCIENCE (2012)
Human T-Lymphoid Progenitors Generated in a Feeder-Cell-Free Delta-Like-4 Culture System Promote T-Cell Reconstitution in NOD/SCID/γc-/- Mice
Christian Reimann et al.
STEM CELLS (2012)
Maintenance of genomic integrity in hematopoietic stem cells
Kazuhito Naka et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
Gene Therapy of Chronic Granulomatous Disease: The Engraftment Dilemma
Manuel Grez et al.
MOLECULAR THERAPY (2011)
Protein Transfer Into Human Cells by VSV-G-induced Nanovesicles
Philippe-Emmanuel Mangeot et al.
MOLECULAR THERAPY (2011)
Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia
David L. Porter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Long-Term Persistence of a Polyclonal T Cell Repertoire After Gene Therapy for X-Linked Severe Combined Immunodeficiency
H. Bobby Gaspar et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency
E. Ayuso et al.
GENE THERAPY (2010)
Mechanisms that determine plasma cell lifespan and the duration of humoral immunity
Ian J. Amanna et al.
IMMUNOLOGICAL REVIEWS (2010)
Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors
Brigitte Anliker et al.
NATURE METHODS (2010)
Engineering human hematopoietic stem/progenitor cells to produce a broadly neutralizing anti-HIV antibody after in vitro maturation to human B lymphocytes
Xin M. Luo et al.
BLOOD (2009)
Wiskott-Aldrich syndrome protein is an effector of Kit signaling
Maheswaran Mani et al.
BLOOD (2009)
Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
Steven J. Howe et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Competence and competition:: the challenge of becoming a long-lived plasma cell
Andreas Radbruch et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Natural gene therapy in monozygotic twins with Fanconi anemia
A Mankad et al.
BLOOD (2006)
Impaired bone marrow homing of cytokine-activated CD34+ cells in the NOD/SCID model
F Ahmed et al.
BLOOD (2004)
Efficient gene transfer into human primary blood lymphocytes by surface-engineered lentiviral vectors that display a T cell-activating polypeptide
M Maurice et al.
BLOOD (2002)
Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction
M Gross et al.
CYTOGENETIC AND GENOME RESEARCH (2002)
分享论文
